Invention is related to novel compounds - 5-aryl-4-(5-substituted 2,4-dihydroxyphenyl)-1,2,3-thiadiazoles with general formula (I). The compounds can be used in biomedicine as active ingredients in pharmaceutical formulations, because they inhibit Hsp90 chaperone which participate in cancer progression. This invention is also related to new intermediate compounds which are used for the synthesis of thiadiazoles of general formula (I).
本发明涉及新型化合物-通式为(I)的5-芳基-4-(5-取代的2,4-二羟基苯基)-1,2,3-
噻二唑。该化合物可用于
生物医学中作为制药配方中的活性成分,因为它们抑制Hsp90伴侣蛋白,参与癌症进展。本发明还涉及用于合成通式(I)
噻二唑的新中间体化合物。